11-5581384-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005162.2(OR52B6):c.508C>T(p.His170Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H170R) has been classified as Likely benign.
Frequency
Consequence
NM_001005162.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR52B6 | ENST00000345043.2 | c.508C>T | p.His170Tyr | missense_variant | 1/1 | 6 | NM_001005162.2 | ENSP00000341581.2 | ||
ENSG00000239920 | ENST00000380259.7 | n.*739+9441G>A | intron_variant | 5 | ENSP00000369609.3 | |||||
ENSG00000239920 | ENST00000394793.3 | n.256-8785G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250434Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135608
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461480Hom.: 0 Cov.: 51 AF XY: 0.00000550 AC XY: 4AN XY: 727046
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2023 | The c.508C>T (p.H170Y) alteration is located in exon 1 (coding exon 1) of the OR52B6 gene. This alteration results from a C to T substitution at nucleotide position 508, causing the histidine (H) at amino acid position 170 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at